It delineates differential gene-expression profiles, transcript splice isoforms, and fusion transcript profiles for CBF AML subtypes, and it also identifies specific genes and pathways that may provide targets for therapeutic intervention. The gene discussed is CEBPZ; the disease is acute myeloid leukemia.